Has Yue Jao Ayala received payments from drug or device companies?

Yes. Drug and device makers reported $5,714 in general payments to Yue Jao Ayala across 109 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Yue Jao Ayala did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Yue Jao Ayala come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Yue Jao Ayala

Gastroenterology · Mayaguez, PRNPI 1952858896

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 109 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 47.4% of the total.

$5,714in general payments, 2019–2025

Across 109 payments — averaging $52.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$3K
Johnson & Johnson$1K
E.r. Squibb & Sons, L.L.C.$575
Madrigal Pharmaceuticals$337
Boehringer Ingelheim$181
Gilead$175
plus $695 from 13 others

What the payments were for

Food & beverage$5,714100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	43	$2,709
Johnson & Johnson(2 entities)	24	$1,042
E.r. Squibb & Sons, L.L.C.	12	$575
Madrigal Pharmaceuticals	3	$337
Boehringer Ingelheim	6	$181
Gilead	2	$175
Lilly USA, LLC	2	$138
Olympus Latin America, Inc.	1	$125
Mirum Pharmaceuticals, Inc.	1	$125
Novartis	3	$49
Eli Lilly Export S.A. Puerto Rico Branch	2	$48
Boston Scientific	2	$43
Amgen	2	$40
Takeda Pharmaceuticals U.S.A., Inc.	1	$33
Bayer Puerto Rico Inc.	1	$25
Bayer	1	$22
PBG Puerto Rico LLC	1	$17
Chiesi USA, Inc.	1	$17
Merck	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,714 in reported general payments places this provider in the 75th percentile of 198 gastroenterology providers in Puerto Rico.

See all gastroenterology providers in Puerto Rico →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Humira(Cf) PenAdalimumab	12	$84,058
Mesalamine	23	$12,084
Sucralfate	14	$2,222
Omeprazole	30	$179
Prednisone	11	$89
Famotidine	15	$79

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Mayaguez

See the full list for Puerto Rico →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →